Cargando…
Serum E-selectin and endothelial cell-specific Molecule-1 levels among people living with HIV on long term ART in Uganda: a pilot cross-sectional study
BACKGROUND: Prolonged exposure to HIV and anti-retroviral therapy (ART) has been linked with endothelial cell activation which subsequently predisposes people living with HIV (PLWH) to cardiovascular diseases. Serum biomarkers of endothelial cell activation such as E-Selectin and endothelial cell-sp...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169468/ https://www.ncbi.nlm.nih.gov/pubmed/37161496 http://dx.doi.org/10.1186/s12981-023-00519-x |
_version_ | 1785039048024260608 |
---|---|
author | Semulimi, Andrew Weil Batte, Charles Bayiyana, Alice Nakabuye, Mariam Mukisa, John Castelnuovo, Barbara Ratanshi, Rosalind Parkes Kirenga, Bruce J Ssinabulya, Isaac |
author_facet | Semulimi, Andrew Weil Batte, Charles Bayiyana, Alice Nakabuye, Mariam Mukisa, John Castelnuovo, Barbara Ratanshi, Rosalind Parkes Kirenga, Bruce J Ssinabulya, Isaac |
author_sort | Semulimi, Andrew Weil |
collection | PubMed |
description | BACKGROUND: Prolonged exposure to HIV and anti-retroviral therapy (ART) has been linked with endothelial cell activation which subsequently predisposes people living with HIV (PLWH) to cardiovascular diseases. Serum biomarkers of endothelial cell activation such as E-Selectin and endothelial cell-specific molecule-1 (ESM-1) could aid in early detection of PLWH at a risk of cardiovascular diseases. However, there is a paucity of data on these biomarkers like E-selectin and endothelial cell-specific molecule-1 (ESM-1) among PLWH on long term ART (≥ 10 years) in Uganda. The aim of this study is to determine the serum levels of these biomarkers in this population. METHODS: This was a cross-sectional study where we randomly sampled 73 stored serum samples of PLWH who were enrolled in the Infectious Diseases Institute (IDI) ART long term (ALT cohort). We measured serum levels of E-selectin and ESM-1 by ELISA. Data was summarized using median and interquartile range. Inferential statistics were performed to determine predictors of elevated levels of E-selectin. RESULTS: Of the 73 samples analyzed, 38 (52.1%) were from female participants. The mean age was 54 ± 9.0 years. Twenty participants (27.4%) had a history of smoking while 52 (71.2%) had a history of alcohol intake. Twenty-five (34.3%) of the participants were overweight whereas 4 (5.6%) were obese. Fifty-four (74%) had an undetectable viral load (≤ 0 copies/ml) and the mean duration of ART at the time of sampling (2014/2015) was 10.4 ± 0.4 years. While serum levels of ESM-1 were not detectable in any of our samples, the median E-selectin levels was 147.6 μm/L ranging from 8.44 μm/L and 1,979.36 μm/L. Sixty-seven participants (91.8%) had elevated levels of E-selectin (> 39 μm/L). CD4 count > 500 cells/µl compared to lower counts was a predictor of elevated levels of E-Selectin (adjusted Odd Ratio 12.5, 95% CI (1.03 — 149.95, p < 0.05). CONCLUSIONS: The majority (91.8%) of PLWH on long term ART had elevated levels of E-selectin. Having high CD4 count (> 500 cells/µl) was predictive of elevated levels of E-Selectin. Future work should longitudinally assess the trend of levels of E-selectin and ESM-1 while assessing for cardiovascular diseases endpoint. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12981-023-00519-x. |
format | Online Article Text |
id | pubmed-10169468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101694682023-05-11 Serum E-selectin and endothelial cell-specific Molecule-1 levels among people living with HIV on long term ART in Uganda: a pilot cross-sectional study Semulimi, Andrew Weil Batte, Charles Bayiyana, Alice Nakabuye, Mariam Mukisa, John Castelnuovo, Barbara Ratanshi, Rosalind Parkes Kirenga, Bruce J Ssinabulya, Isaac AIDS Res Ther Research BACKGROUND: Prolonged exposure to HIV and anti-retroviral therapy (ART) has been linked with endothelial cell activation which subsequently predisposes people living with HIV (PLWH) to cardiovascular diseases. Serum biomarkers of endothelial cell activation such as E-Selectin and endothelial cell-specific molecule-1 (ESM-1) could aid in early detection of PLWH at a risk of cardiovascular diseases. However, there is a paucity of data on these biomarkers like E-selectin and endothelial cell-specific molecule-1 (ESM-1) among PLWH on long term ART (≥ 10 years) in Uganda. The aim of this study is to determine the serum levels of these biomarkers in this population. METHODS: This was a cross-sectional study where we randomly sampled 73 stored serum samples of PLWH who were enrolled in the Infectious Diseases Institute (IDI) ART long term (ALT cohort). We measured serum levels of E-selectin and ESM-1 by ELISA. Data was summarized using median and interquartile range. Inferential statistics were performed to determine predictors of elevated levels of E-selectin. RESULTS: Of the 73 samples analyzed, 38 (52.1%) were from female participants. The mean age was 54 ± 9.0 years. Twenty participants (27.4%) had a history of smoking while 52 (71.2%) had a history of alcohol intake. Twenty-five (34.3%) of the participants were overweight whereas 4 (5.6%) were obese. Fifty-four (74%) had an undetectable viral load (≤ 0 copies/ml) and the mean duration of ART at the time of sampling (2014/2015) was 10.4 ± 0.4 years. While serum levels of ESM-1 were not detectable in any of our samples, the median E-selectin levels was 147.6 μm/L ranging from 8.44 μm/L and 1,979.36 μm/L. Sixty-seven participants (91.8%) had elevated levels of E-selectin (> 39 μm/L). CD4 count > 500 cells/µl compared to lower counts was a predictor of elevated levels of E-Selectin (adjusted Odd Ratio 12.5, 95% CI (1.03 — 149.95, p < 0.05). CONCLUSIONS: The majority (91.8%) of PLWH on long term ART had elevated levels of E-selectin. Having high CD4 count (> 500 cells/µl) was predictive of elevated levels of E-Selectin. Future work should longitudinally assess the trend of levels of E-selectin and ESM-1 while assessing for cardiovascular diseases endpoint. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12981-023-00519-x. BioMed Central 2023-05-09 /pmc/articles/PMC10169468/ /pubmed/37161496 http://dx.doi.org/10.1186/s12981-023-00519-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Semulimi, Andrew Weil Batte, Charles Bayiyana, Alice Nakabuye, Mariam Mukisa, John Castelnuovo, Barbara Ratanshi, Rosalind Parkes Kirenga, Bruce J Ssinabulya, Isaac Serum E-selectin and endothelial cell-specific Molecule-1 levels among people living with HIV on long term ART in Uganda: a pilot cross-sectional study |
title | Serum E-selectin and endothelial cell-specific Molecule-1 levels among people living with HIV on long term ART in Uganda: a pilot cross-sectional study |
title_full | Serum E-selectin and endothelial cell-specific Molecule-1 levels among people living with HIV on long term ART in Uganda: a pilot cross-sectional study |
title_fullStr | Serum E-selectin and endothelial cell-specific Molecule-1 levels among people living with HIV on long term ART in Uganda: a pilot cross-sectional study |
title_full_unstemmed | Serum E-selectin and endothelial cell-specific Molecule-1 levels among people living with HIV on long term ART in Uganda: a pilot cross-sectional study |
title_short | Serum E-selectin and endothelial cell-specific Molecule-1 levels among people living with HIV on long term ART in Uganda: a pilot cross-sectional study |
title_sort | serum e-selectin and endothelial cell-specific molecule-1 levels among people living with hiv on long term art in uganda: a pilot cross-sectional study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169468/ https://www.ncbi.nlm.nih.gov/pubmed/37161496 http://dx.doi.org/10.1186/s12981-023-00519-x |
work_keys_str_mv | AT semulimiandrewweil serumeselectinandendothelialcellspecificmolecule1levelsamongpeoplelivingwithhivonlongtermartinugandaapilotcrosssectionalstudy AT battecharles serumeselectinandendothelialcellspecificmolecule1levelsamongpeoplelivingwithhivonlongtermartinugandaapilotcrosssectionalstudy AT bayiyanaalice serumeselectinandendothelialcellspecificmolecule1levelsamongpeoplelivingwithhivonlongtermartinugandaapilotcrosssectionalstudy AT nakabuyemariam serumeselectinandendothelialcellspecificmolecule1levelsamongpeoplelivingwithhivonlongtermartinugandaapilotcrosssectionalstudy AT mukisajohn serumeselectinandendothelialcellspecificmolecule1levelsamongpeoplelivingwithhivonlongtermartinugandaapilotcrosssectionalstudy AT castelnuovobarbara serumeselectinandendothelialcellspecificmolecule1levelsamongpeoplelivingwithhivonlongtermartinugandaapilotcrosssectionalstudy AT ratanshirosalindparkes serumeselectinandendothelialcellspecificmolecule1levelsamongpeoplelivingwithhivonlongtermartinugandaapilotcrosssectionalstudy AT kirengabrucej serumeselectinandendothelialcellspecificmolecule1levelsamongpeoplelivingwithhivonlongtermartinugandaapilotcrosssectionalstudy AT ssinabulyaisaac serumeselectinandendothelialcellspecificmolecule1levelsamongpeoplelivingwithhivonlongtermartinugandaapilotcrosssectionalstudy |